A Fresh New Look at Labshares: Office Upgrade at 90 Bridge Street
Labshares News
March 20, 2025
Labshares x BYTE51: A Game-Changing Partnership to Navigate Fundraising
Labshares News
August 8, 2018
Harbour BioMed inks $350 million deal for rights to A167
USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
